CLRB
Cellectar Biosciences Inc
NASDAQ: CLRB · HEALTHCARE · BIOTECHNOLOGY
$2.56
-0.02% today
Updated 2026-04-29
Market cap
$11.70M
P/E ratio
—
P/S ratio
348.47x
EPS (TTM)
$-8.35
Dividend yield
—
52W range
$2 – $21
Volume
0.0M
Cellectar Biosciences Inc (CLRB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |